ASHM @ 2017 STI & HIV World Congress
Bloggers
|
PostsMycobacterium in an immunosuppressed HIV patient.
Dr Marcos Davi G. Sousa Specialist in Infectology, Federal Hospital of the Servants of the State of Rio de Janeiro presented a case history of a male,
Congress Summary
How do you summarise such a comprehensive and jam packed conference into one post?!
I have been absolutely overwhelmed by the great presentatio
HIV Self sampling
Findings from the national online HIV self-sampling service in England. (Luis Guerra).
I found this talk to be if interest because in NSW we have lau
Do repeat STI infections increase HIV risk?
This morning I attended the Oral presentations for HIV/STI testing and management, looking at different studies around HIV risk.
Brendan Harney from
The role of mobile applications in STI prevention.
This morning I watched a presentation by Joshua Rosenberger (USA).Examining the role of STI prevention among MSM using mobile applications.
He was di
Evolution and global spread of resistance in Mycoplasma genitalium
Today I watched Catriona Bradshaw (Monash University, Melbourne) present on M.G.
WOW. Great presentation.
M.G Slow to grow and difficult to culture.
Mycoplasma genitalium: an unknown agent.
My focus today was on Mycoplasma Genitalium as it has been a topic of many discussions recently.
Several presenters discussed this topic
Resistance in STIs
Evolution and global spread of resistance in STIs- a very useful and insightful topic and very relevant working clinically in the field of STIs.
Rapid STI diagnosis
I attended a lunch session sponsored by Cepheid regarding rapid STI diagnosis and use of point of care testing.
Working primarily in an Indigenous he
Does Doxycycline Prophylaxis have a future?
The short answer from Jeffery Klausner (UCLA, CA) is; Yes.
Jeffery spoke about the two studies and looked at those results.
Antibiotic prevention is
Neglected STIs
Gwenda Hughes (National Centre for infectious Disease Surveillance and Control at Public Health, UK)
Spoke about some STIs that are neglected or unde
Trichomoniasis/LGV - Ignored?
Why are some common STI's neglected over others?
Gwenda Hughes from the Centre for Infectious Disease Surveillance and Control at Public Health
HCV Infections in HIV negative MSM on PrEP
I attended the oral presentation sessions today on STI Surveillance with four different speakers on the topics of
"A tale of two halves, low extend
Current Trends in Syphilis Testing
During lunch I attended a Roche sponsored integrated symposium titled ´Syphilis, Chlamydia, Gonorrhoea-Oh My: Diagnostic Advances, Hurdles and Conside
Point of care testing for STIs and HIV - A marriage of innovation and technology
Point of care testing - is it the way of the future? Dr Tarim Sadiq (St. George's University of London) Spoke about new POC testing technologies curre
Update on Vaginal Microbiome Research
This morning started with a great presentation of two Plenaries, starting with Vaginal Microbiome Research by Jeanne Marrazo - ISSTDR President and Pr
Vaginal microbiomes and the risks of HIV/STI
The day started with a presentation from Prof. Jeanne Marrozzo, Professor of Medicine and Director of the Division of Infectious Diseases, University
PrEP Implementation: Challenges and Opportunities
Dr Sinead Delany-Moretlwe presented a plenary regaring the implications of implementation of PrEP.
In November 2015 the World Health Organizatio
Keynote speaker! Exciting start to what should be a great conference!
Dr Kevin De Cock delivered an insightful keynote lecture which has set the tone for what should be a very valuable conference.
He presented the
New WHO STI Treatment Guidelines
The new WHO STI Treatment Guidelines were released August 2016 after 3 years of a very complex process, this was the first update sinc
WHO STI Treatment Guidelines 2017
Good morning from the 2017 HIV/STI Conference in Rio De Janeiro. There may be a cross over in some topics with other ASHM bloggers but over th
New WHO Treatment Guidelines 2016.
This morning saw the kick off of the STI and HIV World Congress in Rio de Janeiro Brazil.
First off this morning was the 2016 WHO Treatment guideline
|